Short interest for Bright Mountain Media gives investors a sense of the degree to which investors are betting on the decline of Bright Mountain Media's stock. Short interest data is updated every two weeks.

Bright Mountain Media Stock (OTC:BMTM), Short Interest Report

Bright Mountain Media Inc is a holding company that focuses on digital publishing and advertising technology. The Company is engaged in content creation and advertising technology development that helps customers connect with, and market to, targeted audiences in high-quality environments using a variety of digital ad formats. It generates revenue through sales of advertising services which generate revenue from advertisements placed on the Company's owned and managed sites, as well as from advertisements placed on partner websites, for which the company earns a share of the revenue.

BRIGHT MOUNTAIN MEDIA INC by Bright Mountain Media, Inc.

Bright Mountain Media Inc

Cantor Fitzgerald analyst Sarah James downgrades CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) from Overweight to Neutral and lowers the price target from $87 to $58.

News

Downgrades

Price Target

Analyst Ratings

Cantor Fitzgerald Downgrades CVS Health to Neutral, Lowers Price Target to $58

TD Cowen analyst Yaron Werber maintains Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) with a Buy and raises the price target from $25 to $27.

EXEL

TD Cowen Maintains Buy on Exelixis, Raises Price Target to $27

South Korea&#8217;s Ministry of Culture, Sports, and Tourism aims to bolster the country&#8217;s console gaming sector by 2028, aiming to diversify its gaming industry away from a heavy reliance on <a href="https://www.benzinga.com/markets/asia/24/03/37564487/international-womens-day-spotlight-37-of-asian-gamers-are-women-growth-rate-hits-11">mobile and online platforms. </a>
On Wednesday, the government unveiled its five-year plan, as reported by&nbsp;Yonhap News Agency (<a href="https://www.gamesindustry.biz/korea-plans-to-grow-console-industry-in-the-next-five-years?utm_source=feed&amp;utm_medium=rss&amp;utm_campaign=feed">via</a> GamesIndustry.biz).
See Also: <a href="https://www.benzinga.com/markets/asia/23/01/30547889/the-shifting-paradigms-of-asias-video-game-industry">The Shifting Paradigms of Asia&#8217;s Video Game Industry</a>
Currently, consoles constitute 28% of the global gaming market, yet South Korea&#8217;s share is a mere 1.5%, significantly lagging behind North America and Europe where 40% of players opt for consoles. 
Despite this, South Korea is the fourth-largest gaming market globally, with players spending a substantial 22.2 trillion won ($16.04 billion) on video games annually.
To achieve its goal, the ministry plans to support local developers in collaborating with major console manufacturers such as Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Sony Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) and Nintendo ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NTDOY#OTC">NTDOY</a>) to create new titles over the next five years. 
Additionally, it will offer assistance to independent studios in their endeavors. 
This strategic shift follows reports from last November by Niko Partners, indicating that South Korea&#8217;s PC gaming market accounted for 55% of East Asia&#8217;s gaming revenue. 
Moreover, projections suggest that by 2027, the combined PC and mobile gaming markets in East Asia could reach a staggering $30.8 billion.
Read Next: <a href="https://www.benzinga.com/markets/asia/24/04/38531013/square-enixs-financial-blow-140m-loss-from-game-cancellations">Square Enix&#8217;s Financial Blow: $140M Loss From Game Cancellations</a>
Image created using photos from Canva.

Asia

Gaming

Global

MSFT

NTDOY

Sony Group Corporation American Depositary Shares

SONY

South Korea's 5-Year Plan To Grow Its Console Gaming Market By 2028

TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) with a Buy and lowers the price target from $21 to $20.

TD Cowen Maintains Buy on NeoGenomics, Lowers Price Target to $20

Crypto research firm 10x Research on Wednesday underscored its prediction that the ongoing Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) correction may take prices into <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38555886/this-trader-sees-bitcoin-dropping-to-40-000-and-still-be-fine-expect-lower-prices-but-dont">the low $50,000s.</a>
What Happened: In their latest email <a href="https://10xresearch.co/">newsletter</a>, the team around lead analyst Markus Thielen highlight the differing risk management approaches between institutional investors and retail traders. 
Their research suggests the <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38277523/bitcoin-halving-jitters-why-10x-research-urges-caution">average entry price</a> for U.S. Bitcoin ETF holders sits around $57,300, potentially even higher, a level Bitcoin prices are rapidly approaching.
Despite the predicted correction, 10x Research maintains a positive long-term outlook. 
Bitcoin&#8217;s recent one-year high validates their early 2023 prediction of a new bull market, further reinforced by its proximity to their forecasted halving price of $63,160. 
Additionally, their 2023 year-end target of $45,000 was nearly achieved, and their post-ETF approval target of $57,000, later revised to $70,000, underscores their continuous analysis and adaptation.
Their ability to accurately predict market movements stems from a deep understanding of historical trends and the driving forces within the crypto industry. 
As 10x Research points out in their previous reports, analyzing these factors has been instrumental in their successful predictions throughout the current bull market.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38558934/dont-get-left-behind-web3-wallets-offer-more-than-you-think-in-todays-market">Don&#8217;t Get Left Behind: Web3 Wallets Offer More Than You Think In Today&#8217;s Market</a>
Why It Matters: Looking back, the August 2023 correction was attributed to rising 10-year Treasury bond yields and a hawkish Fed stance, mirroring the situation during the August 2015 RMB devaluation. 
While the initial impact was a sharp decline, Bitcoin ultimately recovered significantly by year-end.
Similar foresight was applied in January 2024, where 10x Research anticipated a correction to $36,000/$38,000, citing the historical tendency for corrections following major Bitcoin product approvals. 
They recommended hedging long exposure but turned bullish again as Bitcoin rebounded, reiterating their $70,000 target.
March 2024 saw another crucial turning point. 
Recognizing the potential for a +/-10% move, 10x Research established a line in the sand at $68,300, indicating a potential significant top if breached. 
This aligns with their current <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38334571/why-bitcoin-could-plummet-to-52-000-10x-research">prediction of a correction</a> towards $52,000/$55,000 within the ongoing bull market.
Several factors contribute to this anticipated correction. 
The research highlights a shift in ETF buying behavior, with six <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38554103/spot-bitcoin-etfs-bled-another-162-million-on-tuesday">consecutive days of outflows</a> observed. 
What&#8217;s Next: As the average entry price of $57,300 is approached, further ETF unwinding is expected, potentially pushing prices down. 
Additionally, the estimated all-in mining cost of $53,000/$55,000 for Bitcoin miners could trigger selling to protect operations.
While a 25% to 29% correction is anticipated, 10x Research acknowledges the possibility of a consolidation period instead of a sharp snapback rally.
As industry leaders gather at events like Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> on Nov. 19th, insights from 10x Research and other experts will be invaluable in navigating the complexities of the current bull market and preparing for potential corrections within the broader landscape.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38547115/ex-binance-ceo-changpeng-zhao-sees-crypto-industry-entering-new-phase">Ex-Binance CEO Changpeng Zhao Sees Crypto Industry Entering &#8216;New Phase&#8217;</a>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Why Bitcoin Might Drop Another 20%: 10x Research

TD Cowen analyst Bryan Bergin maintains PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) with a Hold and raises the price target from $58 to $68.

PYPL

TD Cowen Maintains Hold on PayPal Holdings, Raises Price Target to $68

UBS analyst Peter Grom maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Neutral and lowers the price target from $164 to $159.

UBS Maintains Neutral on Clorox, Lowers Price Target to $159

High-rolling investors have positioned themselves bullish on Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in MO often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 9 options trades for Altria Group. This is not a typical pattern.
The sentiment among these major traders is split, with 44% bullish and 33% bearish. Among all the options we identified, there was one put, amounting to $34,000, and 8 calls, totaling $427,395.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $45.0 for Altria Group, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Altria Group's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Altria Group's whale trades within a strike price range from $30.0 to $45.0 in the last 30 days. 
<h3>Altria Group Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714585558_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$9.25</td>
<td>$9.25</td>
<td>$9.25</td>
<td>$35.00</td>
<td>$138.7K</td>
<td>5.3K</td>
<td style="text-align: right;">155</td>
</tr>
<tr>
<td>MO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.0</td>
<td>$13.85</td>
<td>$14.0</td>
<td>$30.00</td>
<td>$91.0K</td>
<td>215</td>
<td style="text-align: right;">65</td>
</tr>
<tr>
<td>MO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$2.72</td>
<td>$2.61</td>
<td>$2.72</td>
<td>$45.00</td>
<td>$54.8K</td>
<td>2.6K</td>
<td style="text-align: right;">737</td>
</tr>
<tr>
<td>MO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.1</td>
<td>$1.51</td>
<td>$1.7</td>
<td>$37.50</td>
<td>$34.0K</td>
<td>1.0K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$7.35</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$37.50</td>
<td>$33.5K</td>
<td>486</td>
<td style="text-align: right;">50</td>
</tr>
</tbody>
</table>

<h3>About Altria Group</h3>
Altria comprises Philip Morris USA, us Smokeless Tobacco, John Middleton, Horizon Innovations and Helix Innovations. It holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the us with a 42% annual share in 2022. Altria holds a 42% stake in cannabis manufacturer Cronos, acquired Njoy Holdings in 2023, and recently exited its strategic investment in Juul Labs. It operates a joint venture with Japan Tobacco in the heated tobacco category.
<h3>Altria Group's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,043,957, with MO's price up by 0.46%, positioned at $44.01.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 90 days.</li>
</ul>
<h3>Professional Analyst Ratings for Altria Group</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $36.5.
<ul>
<li>An analyst from UBS persists with their Sell rating on Altria Group, maintaining a target price of $36. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Altria Group options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Behind the Scenes of Altria Group's Latest Options Trends

Deep-pocketed investors have adopted a bearish approach towards Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LEN usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Lennar. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 30% leaning bullish and 40% bearish. Among these notable options, 4 are puts, totaling $167,066, and 6 are calls, amounting to $313,190.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $135.0 and $190.0 for Lennar, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Lennar's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lennar's whale activity within a strike price range from $135.0 to $190.0 in the last 30 days. 
<h3>Lennar Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714585553_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LEN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.0</td>
<td>$5.8</td>
<td>$5.8</td>
<td>$190.00</td>
<td>$92.8K</td>
<td style="text-align: right;">377</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>LEN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$12.6</td>
<td>$12.3</td>
<td>$12.5</td>
<td>$160.00</td>
<td>$62.5K</td>
<td style="text-align: right;">116</td>
<td style="text-align: right;">80</td>
</tr>
<tr>
<td>LEN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.5</td>
<td>$8.2</td>
<td>$8.2</td>
<td>$180.00</td>
<td>$62.3K</td>
<td style="text-align: right;">326</td>
<td style="text-align: right;">200</td>
</tr>
<tr>
<td>LEN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/19/24</td>
<td>$13.4</td>
<td>$12.9</td>
<td>$13.12</td>
<td>$160.00</td>
<td>$49.8K</td>
<td style="text-align: right;">490</td>
<td style="text-align: right;">38</td>
</tr>
<tr>
<td>LEN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$13.4</td>
<td>$13.1</td>
<td>$13.22</td>
<td>$160.00</td>
<td>$48.9K</td>
<td style="text-align: right;">490</td>
<td style="text-align: right;">75</td>
</tr>
</tbody>
</table>

<h3>About Lennar</h3>
Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily and single-family for rent construction and has invested in numerous housing-related technology startups.
Following our analysis of the options activities associated with Lennar, we pivot to a closer look at the company's own performance.
<h3>Where Is Lennar Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 547,525, with LEN's price down by -0.02%, positioned at $151.59.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 42 days.</li>
</ul>
<h3>Professional Analyst Ratings for Lennar</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $171.0.
<ul>
<li>Reflecting concerns, an analyst from Wedbush lowers its rating to Underperform with a new price target of $144.</li>
<li>An analyst from Citigroup has decided to maintain their Buy rating on Lennar, which currently sits at a price target of $198. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lennar options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Behind the Scenes of Lennar's Latest Options Trends

Financial giants have made a conspicuous bearish move on Baidu. Our analysis of options history for Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) revealed 12 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 58% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $626,415, and 5 were calls, valued at $240,425.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $95.0 to $160.0 for Baidu during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Baidu's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Baidu's substantial trades, within a strike price spectrum from $95.0 to $160.0 over the preceding 30 days.
<h3>Baidu Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714585548_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$8.75</td>
<td>$8.55</td>
<td>$8.63</td>
<td>$105.00</td>
<td>$431.5K</td>
<td style="text-align: right;">515</td>
<td style="text-align: right;">500</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$14.3</td>
<td>$13.95</td>
<td>$14.3</td>
<td>$110.00</td>
<td>$65.7K</td>
<td style="text-align: right;">940</td>
<td style="text-align: right;">55</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$14.4</td>
<td>$14.3</td>
<td>$14.3</td>
<td>$110.00</td>
<td>$47.1K</td>
<td style="text-align: right;">940</td>
<td style="text-align: right;">34</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$4.75</td>
<td>$4.65</td>
<td>$4.7</td>
<td>$120.00</td>
<td>$46.0K</td>
<td style="text-align: right;">485</td>
<td style="text-align: right;">102</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$56.5</td>
<td>$55.95</td>
<td>$56.5</td>
<td>$160.00</td>
<td>$45.2K</td>
<td style="text-align: right;">35</td>
<td style="text-align: right;">15</td>
</tr>
</tbody>
</table>

<h3>About Baidu</h3>
Baidu is the largest internet search engine in China with 84% share of the search engine market in September 2021 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2022. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
<h3>Present Market Standing of Baidu</h3>
<ul>
<li>Currently trading with a volume of 1,241,294, the BIDU's price is up by 0.96%, now at $104.39. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 15 days.</li>
</ul>
<h3>Professional Analyst Ratings for Baidu</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.5.
<ul>
<li>Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Baidu with a target price of $176. </li>
<li>An analyst from HSBC persists with their Buy rating on Baidu, maintaining a target price of $145. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Baidu with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

BIDU

What the Options Market Tells Us About Baidu

Oil major&nbsp;Shell PLC&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) has reportedly decided to exit China&#8217;s power markets, aligning with CEO Wael Sawan&#8217;s focus on bolstering profitability in its natural gas and oil sectors.
Shell has withdrawn from China&#8217;s power value chain, encompassing generation, trading, and marketing, effective since the close of 2023, according to a report from Reuters.&nbsp;
This move reflects a commitment&nbsp;to selectively invest in profitable ventures within the power sector.
The decision to exit China&#8217;s power market comes amid a broader effort to streamline operations and save up to $3 billion annually.&nbsp;
The changes do not apply to Shell&#8217;s electric vehicle charging business, the report noted, citing a spokesperson.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38484839/legal-battle-unmasks-shells-under-the-radar-oil-trading-earnings-report" rel="noreferrer noopener">Legal Battle Unmasks Shell&#8217;s Under-The-Radar Oil Trading Earnings: Report</a>
Recently, the company set a new ambition to reduce customer emissions from&nbsp;the use of&nbsp;its oil products by 15%-20% by 2030 compared with&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38299595/shell-defends-climate-goals-rejects-shareholder-resolution-as-damaging" rel="noreferrer noopener">2021 and against its previous target of 20%</a>.
Interestingly, Shell had urged shareholders in an AGM notice to vote against an independent resolution, co-filed by a group of 27 investors, that demanded the company set tighter climate targets.
In April, Shell reportedly inked a deal with the Nigerian government to supply gas to the proposed&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38319262/shell-nigeria-ink-gas-deal-to-fuel-3-8b-methanol-project-report" rel="noreferrer noopener">$3.8 billion Brass menthol facility.</a>
Shell stock has gained more than 15% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Direxion Hydrogen ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HJEN#NYSE">HJEN</a>) and&nbsp;VanEck Natural Resources ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAP#NYSE">HAP</a>).
Price Action: SHEL shares are trading lower by 1.20% at $70.80&nbsp;at the last check Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next: <a href="https://www.benzinga.com/markets/equities/24/04/38513380/nigeria-reportedly-audits-shells-1-3b-onshore-oilfield-sale" target="_blank" rel="noreferrer noopener">Nigeria Reportedly Audits Shell&#8217;s $1.3B Onshore Oilfield Sale</a>
Photo via Wikimedia Commons

Equities

Media

General

Market Vectors RVE Hard Assets Producers ETF

HJEN

SHEL

Shell Exits Chinese Power Market, Eyes Gas Growth: Report

Talarya Brands, a pioneering leader in the cannabis industry, today highlighted record-breaking financial and operational performance following the recent Drug Enforcement Administration (DEA) decision to reclassify marijuana from a Schedule 1 to a Schedule 3 substance. This pivotal shift in the regulatory landscape opens up substantial growth opportunities for the company.
Talarya Brands reported a record 26% increase in revenue year over year in Q1, with gross margins expanding by 770 basis points quarter over quarter. The company achieved a new sales record with $5.65 million in Q1 and generated $297,000 in positive cash flow from operations in March alone. And in a rarity for a California operator, Talarya has been consistently EBITDA positive, underscoring its strong financial discipline and operational efficiency.
The company's financial tailwinds, combined with its focus on distressed asset consolidation, make it well positioned to take advantage of the DEA's decision. The company expects the change in regulation to lead to a thawing of cannabis capital markets, make banking easier for the industry, and most notably, liberate the sector from the onerous IRS rule 280-E, which has unfairly required cannabis companies to pay a larger proportion of federal income tax than other businesses. The public markets responded overwhelmingly positively on the heels of the DEA news, with almost all cannabis equities trading sharply higher.
"Talarya Brands is uniquely poised to capitalize on the DEA's rescheduling of marijuana, which we view as a historic step forward for the industry," said Dustin Milner, CEO of Talarya Brands. "Our robust Q1 results reflect our strategic agility and our team's relentless focus on capitalizing on emerging opportunities while maintaining rigorous cost control. With the DEA's decision, we expect margins to grow, financing to become cheaper and ubiquitous, and investments in qualified operators to see healthier returns with lower risk."
Talarya operates with minimal financial encumbrance, free from any senior secured debt financing and with less than $1 million in secured equipment financing. The company's vape product line, including the 6th best-selling live resin cartridge in California, saw a 48% increase in sales year over year. This achievement is part of Talarya's broader success in the cannabis market, where it stands out as one of the few companies to be profitable on a pre-tax basis.

Cannabis

DEA's Rescheduling of Cannabis will Boost Talarya Brands, which, Reports Record Q1 Growth

Medical Marijuana 411 (MM411), a provider of digital cannabis education, has partnered with CReDO Science, helmed by the renowned Dr. Ethan Russo, <a href="https://www.benzinga.com/cannabis">Benzinga Cannabis</a> has learned exclusively. The initiative aims to deliver evidence-based cannabis and endocannabinoid system (ECS) education to a global audience. Dr. Russo, a respected neurologist and cannabis researcher, brings decades of clinical and research experience to this collaboration.
The initial course offering, available in English, Spanish&nbsp;and Japanese, includes eight webinar modules totaling 11 hours of content. &quot;We are thrilled to join forces with CReDO Science to offer this unparalleled digital cannabis education platform,&quot; said MM411 president Christine DeVol. &quot;By combining our expertise in digital education with Dr. Russo&#39;s extensive research and clinical expertise, we are poised to greatly improve the quality of cannabis education available to all.&quot;
Russo highlighted the importance of accurate information amid the misinformation surrounding cannabis: &quot;Cannabis has immense therapeutic potential, but misinformation and stigma often cloud its true benefits and medical use. Through this collaboration with MM411, we hope to empower healthcare professionals, patients, and advocates around the globe with accurate, science-backed knowledge.&quot;
<ul>
<li>Pro tip: Learn more about the future of cannabis research and education at the Benzinga Cannabis Capital Conference this October in Chicago. Hear directly from key industry players and policymakers. Get your tickets now by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank">this link</a>, and access a 20% discount using the code JAVI20.</li>
</ul>
Russo&#39;s courses distill his extensive clinical experience and peer-reviewed research into digestible modules. Detailed citations provide students with further reading, ensuring learners gain comprehensive and up-to-date information about cannabis&#39; medical applications. The course&#39;s goal is to demystify the complex mechanisms through which cannabis components interact with the body, allowing a wide audience, including&nbsp;medical professionals, patients, caregivers, advocates and industry workers&nbsp;to understand the science behind cannabis and the ECS.
This collaboration arrives at a critical time as cannabis use expands worldwide. According to the United Nations World Drug Report 2023, 219 million people globally use cannabis. In the U.S. alone, the 2022 National Survey on Drug Use and Health found that 59 million adults consumed cannabis in the prior year. However, cannabis education remains lacking. A study by Evanoff et al. revealed that 89.5% of American medical school graduates felt unprepared to prescribe medical marijuana, with only 9% of medical school curricula covering the topic.
Check out the courses to learn more about this interesting initiative by following <a href="https://medicalmarijuana411.com/product/foundation-cannabis-therapeutics-dr-russo/">this link</a>.
Cover image generated by AI

Health Care

Exclusives

EXCLUSIVE: Renowned Cannabis Expert Dr. Ethan Russo, MM411 Launch Digital, Multi-Lingual Education Initiative

UBS analyst Joshua Chan maintains Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) with a Buy and lowers the price target from $550 to $510.

UBS Maintains Buy on Gartner, Lowers Price Target to $510

Walgreens Boots Alliance Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is facing tumultuous times as it grapples with a challenging turnaround, leading to a drastic decline in its stock value, marking its worst performance in over five years.&nbsp;
The company&#8217;s shares plummeted by 18% in April, nearing a 26-year low, following a downward revision of its outlook.&nbsp;
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/01113852/newplot-2.png" alt="" class="wp-image-317780" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/01113852/newplot-2.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/01113852/newplot-2-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
This revision was accompanied by concerns over decreased consumer spending and the revelation of a substantial unpaid tax liability amounting to&nbsp;$2.7 billion, adding to the woes of the beleaguered drugstore chain.
In March, Walgreens Boots Alliance reported second-quarter fiscal year 2024 earnings and narrowed the&nbsp;fiscal year&nbsp;2024 adjusted EPS guidance to $3.20-$3.35 versus&nbsp;prior guidance of $3.20-$3.50&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/03/37981845/walgreens-boots-alliance-cuts-higher-end-of-2024-profit-outlook-takes-5-8b-impairment-charge-relate" rel="noreferrer noopener">and consensus of $3.24</a>.
Over the past eight years, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-04-30/walgreens-wba-stock-lashed-as-investors-left-with-nothing-to-go-on?srnd=markets-vp">highlighted</a> that&nbsp;Walgreens&nbsp;has witnessed consistent losses in its stock value, primarily due to its struggle with high debt stemming from an aggressive acquisition spree.&nbsp;
Despite this downturn, the company remains optimistic about its prospects, embarking on a strategic review of its operations to regain investor confidence&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/03/37967312/walgreens-challenges-nearly-1b-arbitration-award-over-alleged-breach-of-covid-19-test-business-con" rel="noreferrer noopener">and reignite growth</a>.
Key&nbsp;management changes, including the departure of former CEO Roz Brewer, have further unsettled investors, with the stock shedding nearly half of its value during her tenure.&nbsp;
The company is now exploring potential separations, including discussions to split from its&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/23/12/36212055/revived-talks-on-uk-boots-separation-walgreens-reportedly-mulls-exit-strategy-amidst-ipo-conside" rel="noreferrer noopener">UK pharmacy chain</a>, Boots, and assessing options for its specialty pharmacy business,&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/01/36761240/walgreens-explores-options-for-shields-health-in-potential-4b-deal-as-part-of-turnaround-strategy" rel="noreferrer noopener">Shields Health Solutions</a>.
However, Wall Street&#8217;s sentiment toward Walgreens remains cautious, with analysts adopting a wait-and-see approach, the Bloomberg report added.
While some anticipate positive outcomes from the strategic review, others express concerns about potential asset monetization, fearing the loss of crucial components of the business or selling assets at a discount.
Amidst these challenges, the broader landscape of the pharmaceutical market also faces turbulence, with&nbsp;Walmart Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) announcing the closure of its primary-care clinics, reflecting the difficulties companies face&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/04/38529328/walmart-to-shut-down-all-clinic-locations-amid-rising-costs-what-it-means-for-your-healthcare" rel="noreferrer noopener">expanding into the sector</a>.
Despite the prevailing skepticism, citing some analysts, Bloomberg highlights potential avenues for Walgreens to improve its fortunes.&nbsp;
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/03/37430360/womens-history-month-pharmacy-chains-cvs-health-walgreens-to-start-dispensing-abortion-pill-mifepr" rel="noreferrer noopener">Women&#8217;s History Month: Pharmacy Chains CVS Health, Walgreens To Start Dispensing Abortion Pill Mifepristone In Select States</a>.
Price Action: WBA shares are down 1.97% at $17.38 at the last check Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Movers

Investor Optimism Dampens as Walgreens Boots Alliance Struggles With Market Turbulence

UBS analyst Colin Langan maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a Neutral and lowers the price target from $146 to $142.

UBS Maintains Neutral on Lear, Lowers Price Target to $142

TD Cowen analyst Jason Seidl maintains ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) with a Buy and lowers the price target from $177 to $148.

ARCB

TD Cowen Maintains Buy on ArcBest, Lowers Price Target to $148

Starbucks Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) shares tanked in early trading on Wednesday, after the company reported a <a href="https://www.benzinga.com/news/earnings/24/05/38537869/starbucks-q2-earnings-and-revenues-miss-estimates">revenue and earnings miss</a>.
The results came amid an <a href="https://www.benzinga.com/calendars/earnings">exciting earnings season</a>. Here are some key analyst takeaways from the release.
<h1 class="wp-block-heading">Stifel On Starbucks</h1>
Analyst Chris O&#8217;Cull maintained a Hold rating while reducing the price target from $90 to $80.
Starbucks offered a "bitter bean to swallow," with its disappointing results for the fiscal second quarter due to "significant transaction weakness in the U.S.," which was "compounded by persistent softness in China," O&#8217;Cull said in a note.
"April&#8217;s trends have remained soft, as the company has grappled with a more selective consumer and struggled to effectively engage occasional customers, leading the company to meaningful reduce FY24 guidance," the analyst wrote. 
Management provided details of actions planned to curb the sales decline, including accelerated product innovations, new marketing tactics and "operational enhancements to improve peak throughput," he added.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">Wedbush On Starbucks</h1>
Analyst Nick Setyan reaffirmed a Neutral rating while cutting the price target from $92 to $81.
Starbucks reported a decline in same-store sales in both U.S. and international, with an 11% downturn in China, Setyan said. The company revised its same-store sales guidance for fiscal 2024, suggesting "continued headwinds," he added.
"FY24 global and U.S. SSS growth are now expected to be in the negative LSD to flat range (prev. 4-6%) versus consensus of 3.4% and 3.7%, respectively," the analyst wrote. "FY24 EPS growth guidance was lowered to flat to +LSD (prev. 15-20%)," he further stated.
<h1 class="wp-block-heading">TD Cowen On Starbucks</h1>
Analyst Andrew Charles reiterated a Hold rating while slashing the price target from $100 to $85.
The performance in the fiscal second quarter is "more pronounced" as this marked the first time since the Starbucks Rewards data started being disclosed in 2013 that Starbucks saw a sequential decline in members, Charles said. He added that members declined by 1.5 million, from 34.3 million to 32.8 million.
"Starbucks quantified a 3% headwind from weather most pronounced in January, with trends qualitatively improving in March following the launch of Lavender, though reflected headwinds that have continued into April," the analyst wrote.
SBUX Price Action: Shares of Starbucks had declined by 17.14% to $73.33 at the time of publication on Wednesday.
Read Next: <a href="https://www.benzinga.com/economics/macro-economic-events/24/05/38554589/manufacturing-activity-gauge-contracts-again-in-april-commodity-costs-hit-produce">Manufacturing Activity Gauge Contracts Again In April: Commodity Costs Hit Producers</a>
Photo: Manu Padilla on Shutterstock

Analyst Color

Earnings Misses

Reiteration

Restaurants

Trading Ideas

SBUX

Starbucks Presents A 'Bitter Bean To Swallow': Analysts Cut Forecasts After FQ2 Results

UBS analyst Dennis Geiger maintains Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Neutral and lowers the price target from $95 to $85.

UBS Maintains Neutral on Starbucks, Lowers Price Target to $85

TD Cowen analyst Gautam Khanna maintains Albany Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIN#NYSE">AIN</a>) with a Buy and lowers the price target from $106 to $95.

TD Cowen Maintains Buy on Albany Intl, Lowers Price Target to $95

Bright Mountain Media GAAP EPS of -$0.03, revenue of $1.5M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Editor&rsquo;s note: &ldquo;A Golden Ticket to Profiting From &lsquo;Hidden&rsquo; Bull Markets&rdquo; was previously published in January 2023. It has since been updated to include the most relevant information available.
What if I told you that <a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570">one tiny sector</a> of the stock market was regularly responsible for more than 30% of the market&rsquo;s biggest winners?
Not just right now but every day, week, month, year.
You&rsquo;d look at me skeptically. Maybe you&rsquo;d call me crazy. But, nonetheless, it is true.
I&rsquo;m looking at this year&rsquo;s leaderboard right now; five of the top 10 best-performing stocks are from this tiny sector.
Over the past year, this sector accounts for six of the top 10 best-performing stocks.
In 2021, it accounted for four of the top 10 stocks.
In 2020, five of the top 10 stocks were from this sector.
And in 2019, three of the top 10 stocks were from this sector.
Pretty amazing, right? 
One tiny sector of the market &ndash; which, by my calculation, collectively accounts for less than 1% of the market&rsquo;s total value &ndash; regularly accounts for more than 30% of the market&rsquo;s best-performing stocks.
These are the most explosive stocks in the market.
But they have one fatal flaw: They&rsquo;re exceptionally risky.
So far in 2023, this sector accounts for five of the top 10 best-performing stocks. It also accounts for four of the 10 worst-performing stocks.
This sector is the quintessence of high-risk, high-reward.
That&rsquo;s probably why you and 99% of investors avoid this sector altogether. It&rsquo;s too risky.
But what if there is a way to invest in the sector while mitigating risk? What if there was a way to tap into this sector&rsquo;s regularly huge profit potential while reducing downside exposure?
Theoretically, that would be the best trading strategy on the planet.
<a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570">Well, it is a trading strategy we just developed. </a>
Here&rsquo;s a deeper look.
<h2>A Bull Market Is Always Roaring</h2>
No matter what&rsquo;s going on with the broad market indices or how many crises might be popping up around the globe, there&rsquo;s always a sector, an asset class, or a group of stocks that&rsquo;s surging &ndash; and making its investors fistfuls of money.
Why? Because we live in an $80 trillion global economy.
That&rsquo;s a lot of money. In fact, it&rsquo;s so much money that it&rsquo;s guaranteed not all of it will always move in the same direction.
Let&rsquo;s pull out the sports analogies.
Even the worst free-throw shooter in the world will hit at least a few throws if you give them 80 trillion shots. Even the worst batter will hit the ball a few times if you pitch to them 80 trillion times.
By the same token, even a few stocks will rise in the worst of macroeconomic conditions if you give those stocks $80 trillion to work with.
In our global economy, something is always going up, and something is always going down. Both are always true.
So, instead of focusing on what &ldquo;the market&rdquo; is doing, I recommend this. Keep in mind that it&rsquo;s not so much a stock market as it is a market of stocks.
And thanks to those stocks&rsquo; wildly differing fates, <a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570" target="_blank">there&rsquo;s always a bull market printing money for investors who know where to look.</a>

<h2>Huge Opportunity in Hidden Bull Markets</h2>
Let&rsquo;s take this a step further to make sure we&rsquo;re on the same page.
When I write &ldquo;bull market,&rdquo; I don&rsquo;t mean gains of 25%, 30%, or even 50%.
Now, I&rsquo;m not scoffing at those returns. Who doesn&rsquo;t want to make 50% on an investment?
But what <a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570" target="_blank">I&rsquo;m talking about is 100%-plus returns in a single year</a>. And again, this is regardless of what&rsquo;s happening in the S&amp;P 500 or the Nasdaq, the commodities market, or elsewhere.
Let&rsquo;s put some real numbers on this so that you can see for yourself.
In 2018, the S&amp;P fell by 6.24% for the entire year.
Meanwhile, over that same 12-month period, Bright Mountain Media (<a href="https://investorplace.com/stock-quotes/bmtm-stock-quote/">BMTM</a>) soared 360%. Twilio (<a href="https://investorplace.com/stock-quotes/twlo-stock-quote/">TWLO</a>) climbed 278%. Vericel (<a href="https://investorplace.com/stock-quotes/vcel-stock-quote/">VCEL</a>) rose 219%, and American Superconductor (<a href="https://investorplace.com/stock-quotes/amsc-stock-quote/">AMSC</a>) jumped 207%.
<a href="https://investorplace.com/wp-content/uploads/2022/08/theres-always-a-bull-market-somewhere.png"><img src="https://investorplace.com/wp-content/uploads/2022/08/theres-always-a-bull-market-somewhere.png" alt="A graph showing the change in the SPX, TWLO, VCEL, and AMSC over time" width="540" height="370"></a>
In 2019, the S&amp;P had a great year, up 29%.
But that bull market was nothing compared to what happened for Axsome Therapeutics (<a href="https://investorplace.com/stock-quotes/axsm-stock-quote/">AXSM</a>), which erupted 3,565% over those same 12 months, Relmada Therapeutics (<a href="https://investorplace.com/stock-quotes/rlmd-stock-quote/">RLMD</a>), up 748%. Not to mention EverQuote (<a href="https://investorplace.com/stock-quotes/ever-stock-quote/">EVER</a>), which climbed 722%, or AVITA Medical (<a href="https://investorplace.com/stock-quotes/rcel-stock-quote/">RCEL</a>), up 713%.
<a href="https://investorplace.com/wp-content/uploads/2022/08/theres-always-a-bull-market-somewhere-2.png"><img src="https://investorplace.com/wp-content/uploads/2022/08/theres-always-a-bull-market-somewhere-2.png" alt="A graph showing the change in the SPX, AXSM, RLMD, EVER, and RCEL over time" width="540" height="381"></a>
And that brings us to 2020 and the COVID-19 pandemic. Despite falling more than 30% during the bear-market low, the S&amp;P climbed 16% on the year.
Meanwhile, Blink Charging (<a href="https://investorplace.com/stock-quotes/blnk-stock-quote/">BLNK</a>) made its investors 2,190%. Voyager Digital (<a href="https://investorplace.com/stock-quotes/vygvq-stock-quote/">VYGVQ</a>) returned 1,983%. Beam Global (<a href="https://investorplace.com/stock-quotes/beem-stock-quote/">BEEM</a>) soared 1,483%. FingerMotion (<a href="https://investorplace.com/stock-quotes/fngr-stock-quote/">FNGR</a>) added 1,084%, and Plug Power (<a href="https://investorplace.com/stock-quotes/plug-stock-quote/">PLUG</a>) climbed 973%.
That&rsquo;s all in just one year.
<a href="https://investorplace.com/wp-content/uploads/2022/08/theres-always-a-bull-market-somewhere-3.png"><img src="https://investorplace.com/wp-content/uploads/2022/08/theres-always-a-bull-market-somewhere-3.png" alt="A graph showing the change in the SPX, VYGVQ, BLNK, BEEM, FNGR, and PLUG over time" width="540" height="391"></a>
Even in 2022, with the worst inflation in 40 years and stocks getting pummeled, you&rsquo;re kidding yourself if you think there weren&rsquo;t localized bull markets.
Take energy and <a href="https://investorplace.com/industries/industrial/shipping/">shipping stocks</a>, for instance.
Thanks to the Russia-Ukraine war and severe tightness in the oil market, the price of oil stayed high in Q1 and Q2 of 2022. That sent oil and gas stocks soaring and allowed some traders to make a lot of money in <a href="https://investorplace.com/industries/energy/oil/">oil stocks</a>.
This was also a huge boon for certain shipping stocks that load exports of diesel and gasoline.
You could have done well with any of the big oil names &ndash; Exxon (<a href="https://investorplace.com/stock-quotes/xom-stock-quote/">XOM</a>), Chevron (<a href="https://investorplace.com/stock-quotes/cvx-stock-quote/">CVX</a>), or BP (<a href="https://investorplace.com/stock-quotes/bp-stock-quote/">BP</a>). In the first half of the year, they gained between roughly 30% and 50%.
But a moment ago, we talked about 100%-plus returns.
Well, by late summer of 2022, ProShares Ultra Natural Gas (<a href="https://investorplace.com/stock-quotes/boil-stock-quote/">BOIL</a>) had popped 305% on the year. BP Prudhoe Bay Royalty Trust (<a href="https://investorplace.com/stock-quotes/bpt-stock-quote/">BPT</a>) was up 470%. And Scorpio Tankers (<a href="https://investorplace.com/stock-quotes/stng-stock-quote/">STNG</a>) had risen 225%.
Again, this is in less than eight months &ndash; and during a broad bear market.
This is not an anomaly.
These individualized bull markets happen all the time, and they make their investors life-changing returns.
So, the question becomes: how do you find these mega winners?
Well, that brings us to our <a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570" target="_blank">brand-new quantitative system.</a>

<h2>The Final Word on Finding Bull Markets</h2>
<a href="https://investorplace.com/industries/technology/">Tech stocks</a>, <a href="https://investorplace.com/industries/technology/artificial-intelligence/">AI stocks</a>, <a href="https://investorplace.com/industries/technology/semiconductor/">semiconductor stocks</a>, and housing stocks are all in a bull market.
There are bull markets literally everywhere right now.
But none are as explosive as the hidden bull market we&rsquo;ve found to be the <a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570">most explosive corner of the market.</a> It&rsquo;s a corner that, on any given day, week, month, or year, accounts for more than 30% of the market&rsquo;s top performing stocks.
There are literally hundreds of stocks in this specific hidden bull market that could soar 1,000% in less than a year.
Of course, there&rsquo;s a catch: Investing in this particular hidden bull market can be exceptionally risky.
But my team and I just developed an AI-driven quantitative trading model to remove the guesswork and reduce the risk from investing in this particularly explosive sector.
<a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570">We&rsquo;ve developed a &ldquo;smart&rdquo; way to invest in the most explosive hidden bull market on Wall Street.</a>
But know that this corner of the market is only for the most serious traders.
High-risk, high-reward.
If that sounds like you, then I urge you to attend our Grand Debut event on Tuesday, July 11, at 7 p.m. EST, when we will unveil this high-octane quantitative trading system for the very first time.
<a href="https://signup.investorplace.com/?cid=MKT747917&amp;eid=MKT749570">Reserve your seat now.</a>
On the date of publication, Luke Lango did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2022/07/little-known-apple-project/?cid=MKT639809&amp;eid=MKT739312">Buy This $5 Stock BEFORE This Apple Project Goes Live</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/did-elon-musk-just-trigger-a-new-netscape-moment/?cid=MKT738510&amp;eid=MKT741575">Did Elon Musk Just Trigger a New Netscape Moment?</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT739344">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT738955">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/hypergrowthinvesting/2023/07/a-golden-ticket-to-beat-the-fed-and-profit-in-hidden-bull-markets/">A Golden Ticket to Profiting From &#8216;Hidden&#8217; Bull Markets</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.